Kiran Mazumdar Shaw says Biocon's balance sheet "remains very strong"
Biocon released its earnings, conference with Kiran Mazumdar Shaw, who says the balance sheet remains very strong, research services and branded formulations businesses have been the stronges; especially the former which has grown 30%. Says that most profit definately has to be contributed to the new businesses, and that they are trying to reshape the old businesses to increase earnings.
